Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Cavender 1
As Jill Greer, RD, explains: "Tirzepatide's dual receptor action results in stronger effects on blood sugar control and weight reduction compared to a GLP-1 receptor agonist alone." This difference in how the drugs work is the main reason for the gap in their effectiveness
The compound doesn't distinguish circadian time from meal time
The use of nucleic acids or nucleic acid analogues that may alter genome sequences and/ or alter gene expression by any mechanism
Glucagon-like peptide-1 (GLP-1) receptor agonistsincluding semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)along with tirzepatide (Mounjaro, Zepbound), a dual GIP/GLP-1 receptor agonist, have transformed the management of type 2 diabetes and obesity
US$ 24.55
US$ 27.64
US$ 25.47
US$ 27.64
